LURBINECTEDIN for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where LURBINECTEDIN was used for Bladder cancer.
Most Reported Side Effects for LURBINECTEDIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 129 | 13.4% | 129 | 11 |
| Disease progression | 98 | 10.1% | 28 | 14 |
| Off label use | 69 | 7.1% | 6 | 10 |
| Neutropenia | 59 | 6.1% | 12 | 28 |
| Nausea | 58 | 6.0% | 5 | 15 |
| Thrombocytopenia | 48 | 5.0% | 9 | 22 |
| Fatigue | 43 | 4.5% | 3 | 5 |
| Febrile neutropenia | 39 | 4.0% | 9 | 29 |
| Vomiting | 37 | 3.8% | 5 | 14 |
| Asthenia | 36 | 3.7% | 1 | 13 |
| Anaemia | 34 | 3.5% | 5 | 16 |
| Injection site reaction | 32 | 3.3% | 0 | 0 |
| Acute kidney injury | 28 | 2.9% | 7 | 24 |
| Pneumonia | 27 | 2.8% | 11 | 19 |
| Diarrhoea | 25 | 2.6% | 4 | 12 |
Other Indications for LURBINECTEDIN
Small cell lung cancer (351)
Product used for unknown indication (250)
Small cell lung cancer metastatic (106)
Small cell lung cancer extensive stage (56)
Lung neoplasm malignant (41)
Bronchial carcinoma (10)
Neoplasm malignant (8)
Small cell carcinoma (7)
Small cell lung cancer recurrent (7)
Lung carcinoma cell type unspecified stage 0 (6)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)